Abstract

This paper provides large-sample evidence that poison pill rights issues, control share laws, and business combination laws have not systematically deterred takeovers and are unlikely to have caused the demise of the 1980s market for corporate control, even though 87% of all exchange-listed firms are now covered by one of these antitakeover measures. We show that poison pills and control share laws are reliably associated with higher takeover premiums for selling shareholders, both unconditionally and conditional on a successful takeover, and we provide updated event study evidence for the three-quarters of all poison pills not yet analyzed. Antitakeover measures increase the bargaining position of target firms, but they do not prevent many transactions.

Keywords

ShareholderPillDemiseMarket for corporate controlDeterrence theoryBusinessTender offerPosition (finance)Event studyDeterrence (psychology)Securities fraudControl (management)Monetary economicsCorporate governanceEconomicsLaw and economicsFinanceLawPolitical scienceMedicine

Affiliated Institutions

Related Publications

Publication Info

Year
1995
Type
article
Volume
39
Issue
1
Pages
3-43
Citations
799
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

799
OpenAlex
75
Influential
534
CrossRef

Cite This

Robert Comment, G. William Schwert (1995). Poison or placebo? Evidence on the deterrence and wealth effects of modern antitakeover measures. Journal of Financial Economics , 39 (1) , 3-43. https://doi.org/10.1016/0304-405x(94)00823-j

Identifiers

DOI
10.1016/0304-405x(94)00823-j

Data Quality

Data completeness: 81%